Rajdeep Das, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
DepartmentRadiation Oncology
Address1450 Third St
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    The University of Adelaide2016Dean's Commendation for Doctoral Thesis Excellence
    Rashid bin Humaid Award for Culture and Sciences20151st prize for scientific work on extended spectrum beta- lactamase (ESBL)
    The Hospital Research Foundation, Australia2015  - 2015The Hospital Research Foundation 50th Anniversary Award
    Rashid bin Humaid Award for Culture and Sciences20142nd prize for scientific work on methicillin resistance staphylococcus aureus (MRSA)
    Department of Education and Training, Government of Australia and The University of Adelaide2013  - 2016International postgraduate research scholarship (IPRS)
    Gordon Research Conference2015Invited Gordon Research Symposium speaker: Hormone-Dependent Cancer

    Collapse Overview 
    Collapse Overview
    I am a clinically trained pathologist focused on clinical and translational research aimed at improving outcomes for patients with genitourinary cancers. My research interest include the discovery of prognostic/predictive biomarkers in genitourinary cancers and the development of a comprehensive understanding of underlying molecular mechanisms of cancer metastasis.

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Paltoglou S, Das R, Townley SL, Hickey T, Tarulli G, Coutinho I, Fernandes RC, Hanson A, Denis I, Carroll J, Dehm SM, Raj GV, Plymate S, Tilley WD, Selth LA. Novel androgen receptor co-regulator GRHL2 exerts both oncogenic and anti-metastatic functions in prostate cancer. Cancer Res. 2017 May 04. PMID: 28473532.
      View in: PubMed
    2. Quigley D, Alumkal JJ, Wyatt AW, Kothari V, Foye A, Lloyd P, Aggarwal R, Kim W, Lu E, Schwartzman J, Beja K, Annala M, Das R, Diolaiti M, Pritchard CC, Thomas GV, Tomlins SA, Knudsen KE, Lord CJ, Ryan CJ, Youngren J, Beer TM, Ashworth A, Small EJ, Feng FY. Analysis of Circulating Cell-free DNA Identifies Multi-clonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors. Cancer Discov. 2017 Apr 27. PMID: 28450426.
      View in: PubMed
    3. Tse BW, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman ML, McPherson SJ, Roshan-Moniri M, Butler MS, Caradec J, Gregory-Evans CY, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer EM, Jenkins RB, Ross AE, Karnes RJ, Den RB, Fazli L, Gregory PA, Gleave ME, Williams ED, Rennie PS, Buttyan R, Gunter JH, Selth LA, Russell PJ, Nelson CC, Hollier BG. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene. 2017 Jan 16. PMID: 28092670.
      View in: PubMed
    4. Das R, Gregory PA, Fernandes RC, Denis I, Wang Q, Townley SL, Zhao SG, Hanson A, Pickering MA, Armstrong HK, Lokman NA, Ebrahimie E, Davicioni E, Jenkins RB, Karnes RJ, Ross AE, Den RB, Klein EA, Chi KN, Ramshaw HS, Williams ED, Zoubedi A, Goodall GJ, Feng FY, Butler LM, Tilley WD, Selth LA. MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2. Cancer Res. 2016 Dec 23. PMID: 28011622.
      View in: PubMed
    5. Armstrong HK, Koay YC, Irani S, Das R, Nassar ZD, Selth LA, Centenera MM, McAlpine SR, Butler LM. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response. Prostate. 2016 Dec; 76(16):1546-1559. PMID: 27526951.
      View in: PubMed
    6. Selth LA, Das R, Townley SL, Coutinho I, Hanson AR, Centenera MM, Stylianou N, Sweeney K, Soekmadji C, Jovanovic L, Nelson CC, Zoubeidi A, Butler LM, Goodall GJ, Hollier BG, Gregory PA, Tilley WD. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer. Oncogene. 2016 Jun 06. PMID: 27270433.
      View in: PubMed
    7. Das R, Gregory PA, Hollier BG, Tilley WD, Selth LA. Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends Mol Med. 2014 Nov; 20(11):643-51. PMID: 25262538.
      View in: PubMed
    Rajdeep's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP